SCHEMBL6767112

SCHEMBL6767112

COc1cccc(-n2nc(C(C)(C)C)c3c2CC(C)(C)CC3=O)c1

nearest known ligand 0.58

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 11/20 0.58
RIPK2 O43353 1/20 0.48
SRC P12931 2/20 0.48
HSP90AB1 P08238 2/20 0.47
TP53 P04637 2/20 0.47
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6766480 0.86 OPRM1 (0.57) OPRM1SRCHSP90AB1
SCHEMBL6772954 0.86 OPRM1 (0.78) OPRM1HSP90AB1TP53
SCHEMBL6165217 0.85 OPRM1 (0.53) OPRM1SRCHSP90AB1
SCHEMBL6777174 0.82 OPRM1 (0.58) OPRM1SRCHSP90AB1TP53CA1
SCHEMBL6771516 0.82 OPRM1 (0.58) OPRM1SRCHSP90AB1TP53CA1
SCHEMBL6771869 0.82 RIPK2 (0.50) OPRM1RIPK2SRCCA1
SCHEMBL6769486 0.82 OPRM1 (0.55) OPRM1SRCHSP90AB1TP53CA1
SCHEMBL6771525 0.81 OPRM1 (0.50) OPRM1SRCHSP90AB1TP53CA1
SCHEMBL6770581 0.81 ALDH1A1 (0.62) OPRM1HSP90AB1TP53CA1CA2
SCHEMBL6766708 0.80 RIPK2 (0.48) OPRM1RIPK2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed